ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference

19 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

18 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021

04 Oct 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021

01 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference

23 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations

08 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

02 Sep 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN

16 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

11 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System

10 Aug 2021 15:30:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®

09 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021

04 Aug 2021 06:00:03 By Nasdaq GlobeNewswire

ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection

20 Jul 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

14 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference

26 May 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments

12 May 2021 15:05:02 By Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021

05 May 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale

28 Apr 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.

26 Apr 2021 07:00:02 By Nasdaq GlobeNewswire

ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting

13 Apr 2021 07:00:01 By Nasdaq GlobeNewswire